All Stories

  1. A case study applying a novel approach to estimate the social impact of a medical innovation - the use of secukinumab for psoriatic arthritis in Germany

    Article • Expert Review of Pharmacoeconomics & Outcomes Research, July 2019, Taylor & Francis

    Malina Müller

  2. Long-term health benefits of stroke prevention with apixaban versus vitamin K antagonist warfarin in patients with non-valvular atrial fibrillation in Germany: a population-based modelling study

    Article • Expert Review of Pharmacoeconomics & Outcomes Research, October 2018, Taylor & Francis

    Malina Müller